Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,066 | 15,572 | 17,336 | 19,697 | 20,517 |
| Other current assets | 0 | 37 | 37 | 0 | 0 |
| TOTAL | $14,416 | $15,947 | $17,515 | $19,893 | $20,824 |
| Non-Current Assets | |||||
| PPE Net | 8,694 | 8,805 | 8,945 | 8,935 | 9,085 |
| Intangibles | 342 | 344 | 346 | 348 | 350 |
| Other Non-Current Assets | 43 | 49 | 4 | 3 | 4 |
| TOTAL | $9,079 | $9,198 | $9,294 | $9,286 | $9,439 |
| Total Assets | $23,495 | $25,145 | $26,810 | $29,179 | $30,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 95 | 165 | N/A | 24 | 95 |
| Accounts payable and accrued liabilities | 272 | 197 | 320 | 821 | 232 |
| Accrued Expenses | 46 | 25 | 24 | 24 | 24 |
| TOTAL | $413 | $387 | $344 | $870 | $351 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $413 | $387 | $344 | $870 | $351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,592 | 11,554 | 11,534 | 11,525 | 11,515 |
| Common Shares | 0 | 12 | 12 | 12 | 12 |
| Retained earnings | -122,492 | -120,712 | -118,920 | -116,998 | -114,385 |
| Other shareholders' equity | 0 | 1 | 1 | 1 | 0 |
| TOTAL | $23,082 | $24,758 | $26,465 | $28,309 | $29,911 |
| Total Liabilities And Equity | $23,495 | $25,145 | $26,810 | $29,179 | $30,262 |